XL-888

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameXL-888
Drug Alias NameHeat Shock Protein 90 Inhibitor XL888Hsp90 Inhibitor XL888EXEL-4888XL-888
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsSkin NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesH Lee Moffitt Cancer Center & Research InstituteExelixis IncEmory University
Inactive CompaniesN/A
Active IndicationsSkin NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A